Annual Reports & Fin Stmts
January 19 2007 - 10:48AM
UK Regulatory
RNS Number:8647P
The Wellcome Trust
19 January 2007
The Wellcome Trust and Wellcome Trust Finance plc have today published their
2006 Annual Reports and Financial Statements. These are available from the
Trust's website www.wellcome.ac.uk.
Bill Castell, chairman of the Wellcome Trust, said:
'Sir Henry Welcome's last will and testament established the Wellcome Trust in
1936 and since then it has been a force for the advancement of our understanding
of human and animal health and disease. This potential has grown over the last
decade with the significant increases we have seen in our endowment as our
portfolio diversified.
In the last financial year to 30 September 2006, expenditure on charitable
activities in support of our mission totalled #484 million. This was made
possible by the good returns on our investment portfolio, where we achieved an
overall return of 12.8%, and the investment asset base rose to #13.9 billion
(including the proceeds of the #550 million bond issue in July 2006).
There has been important diversification of the portfolio during the year, with
increases in the use of hedge funds, the instigation of an active currency
strategy, and a reduction in equities managed by UK managers. Our investment
portfolio was further enhanced when, in July 2006, we became both the only UK
domiciled non-public sector organisation with a AAA/Aaa credit rating and the
first UK charity to issue listed bonds. The #550 million bond issue should
enable us to generate more income over the long term to support our mission.
Basic research underpins future discovery and application. The support of
investigator led research and career initiatives therefore remains the single
biggest element of our funding portfolio. The primary focus of this activity is
in the UK, where we provided #278 million during the financial year to support
biomedical research.
Our focus over the next year will remain to fund the best people, with the best
ideas, in the best environments and to create the investment returns which we
need to provide the funds. We expect to see growth in our funding for both
clinical research and our research activities overseas. Another key activity
will be the preparation for the opening next summer of Wellcome Collection at
183 Euston Road in London and ensuring its ongoing success.
There is much to be done globally in facing the challenges to the health of
humankind and we are looking forward to the opportunities and challenges the
year will no doubt present.'
215 Euston Road London NW1 2BE UK
T+44 (0)20 7611 8866 F+44 (0)20 7611 8416 www.wellcome.ac.uk
Registered charity No.210183 Trustee; The Wellcome Trust Limited
Registered in England No.2711000
Registered office 215 Euston Road London NW1 2BE
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCILFVRLIIALID
Wellcome 4.625% (LSE:57MC)
Historical Stock Chart
From Nov 2024 to Dec 2024
Wellcome 4.625% (LSE:57MC)
Historical Stock Chart
From Dec 2023 to Dec 2024